Join the 200th Anniversary Celebration

Original Article

Reduced Lung Function at Birth and the Risk of Asthma at 10 Years of Age

Geir Håland, M.D., Karin C. Lødrup Carlsen, M.D., Ph.D., Leiv Sandvik, Ph.D., Chandra Sekhar Devulapalli, M.D., Monica Cheng Munthe-Kaas, M.D., Morten Pettersen, M.D., and Kai-Håkon Carlsen, M.D., Ph.D. for ORAACLE

N Engl J Med 2006; 355:1682-1689October 19, 2006

Abstract

Background

Reduced lung function in early infancy has been associated with later obstructive airway diseases. We assessed whether reduced lung function shortly after birth predicts asthma 10 years later.

Methods

We conducted a prospective birth cohort study of healthy infants in which we measured lung function shortly after birth with the use of tidal breathing flow-volume loops (the fraction of expiratory time to peak tidal expiratory flow to total expiratory time [t PTEF/t E]) in 802 infants and passive respiratory mechanics, including respiratory-system compliance, in 664 infants. At 10 years of age, 616 children (77%) were reassessed by measuring lung function, exercise-induced bronchoconstriction, and bronchial hyperresponsiveness (by means of a methacholine challenge) and by conducting a structured interview to determine whether there was a history of asthma or current asthma.

Results

As compared with children whose t PTEF/t E shortly after birth was above the median, children whose t PTEF/t E was at or below the median were more likely at 10 years of age to have a history of asthma (24.3% vs. 16.2%, P=0.01), to have current asthma (14.6% vs. 7.5%, P=0.005), and to have severe bronchial hyperresponsiveness, defined as a methacholine dose of less than 1.0 μmol causing a 20% fall in the forced expiratory volume in 1 second (FEV1) (9.1% vs. 4.9%, P=0.05). As compared with children whose respiratory-system compliance was above the median, children with respiratory compliance at or below the median more often had a history of asthma (27.4% vs. 14.8%; P=0.001) and current asthma (15.0% vs. 7.7%, P=0.009), although this measure was not associated with later measurements of lung function. At 10 years of age, t PTEF/t E at birth correlated weakly with the maximal midexpiratory flow rate (r=0.10, P=0.01) but not with FEV1 or forced vital capacity.

Conclusions

Reduced lung function at birth is associated with an increased risk of asthma by 10 years of age.

Media in This Article

Table 1Baseline Characteristics of the Children at or Shortly after Birth.
Table 2Lung Function at Birth According to the Presence or Absence of a History of Asthma during the First 10 Years of Life and the Presence of Asthma at 10 Years of Age.
Article

Studies indicate that measurements of lung function early in life are predictive of the presence or absence of respiratory disease in early childhood. An increased risk of wheezing in the first years of life has been reported in children who have increased airway resistance and reduced specific airway conductance in the first week of life,1 in those who have a reduced ratio of expiratory time to peak tidal expiratory flow to total expiratory time (t PTEF/t E) during tidal breathing measured in the first week1 or at 3 months of age,1,2 and in those who have reduced maximal expiratory flow at functional residual capacity (V̇maxFRC) at 1, 3, or 6 months of age.2-5 Similarly, a reduced t PTEF/t E shortly after birth is associated with an increased risk of recurrent bronchial obstruction6 and doctor-diagnosed asthma by 2 years of age.7

The associations are less clear between lung function at or shortly after birth and obstructive airway disease in later childhood. To our knowledge, no study to date has shown an association between lung function in early infancy and asthma after 3 years of age, although wheezing has been found more frequently in school-age children with reduced V̇maxFRC at 1 month of age.8 We assessed the predictive value of lung function shortly after birth for the development of asthma and for markers of obstructive airway diseases by 10 years of age in children enrolled in the Environment and Childhood Asthma (ECA) study, a prospective cohort study of infants enrolled at birth.

Methods

Study Design

The ECA study, established in 1992, involved 3754 healthy, term infants born in Oslo during a period of 15 months9 (see the Supplementary Appendix, available with the full text of this article at www.nejm.org). Newborn babies were enrolled after written informed consent had been obtained from the parents or guardians. The study was approved by the regional medical ethics committee and the Norwegian Data Inspectorate.

Lung function was assessed shortly after birth (mean [±SD] age, 2.7±0.9 days)9 by tidal breathing flow-volume loops (802 infants) and passive respiratory mechanics (664 infants) in all available (unselected) children in the largest maternity ward at Ullevål University Hospital.10

In 2001 we initiated a 10-year follow-up study, which included the 802 subjects in whom lung-function measurements had been performed shortly after birth.11 All children who could be contacted were invited to attend two clinical visits, which included measurements of lung function by forced expiratory flow-volume loops, bronchial hyperresponsiveness to methacholine,12 and exercise-induced bronchoconstriction by treadmill exercise testing13; a skin-prick test for allergic sensitization (see the Supplementary Appendix); a clinical examination; and an extensive interview with the child's parent or guardian that included the International Study of Asthma and Allergies in Childhood (ISAAC) core questions about airway symptoms, as well as questions about the use or nonuse of antiasthmatic medication and about whether a doctor had made a diagnosis of asthma.11 The ISAAC questions have been translated into Norwegian and validated.14 Those who conducted interviews and performed assessments were unaware of the results of lung-function measurements performed shortly after the birth of the infants.

Definitions

On the basis of the interviews, a diagnosis of a history of asthma was made if a child had ever met at least two of the following three criteria: reported dyspnea, chest tightness, or wheezing; a diagnosis of asthma by a doctor; and reported use of asthma medication (e.g., beta-agonists, cromolyn sodium, corticosteroids, leukotriene antagonists, and aminophylline).11 Current asthma was defined as a history of asthma, plus at least one of the following: reported dyspnea, chest tightness, or wheezing during the previous 12 months; reported use of asthma medication (e.g., beta-agonists, cromolyn sodium, corticosteroids, leukotriene antagonists, and aminophylline) during the previous 12 months; and a positive exercise test (a decrease in forced expiratory volume in 1 second [FEV1] of 10% or more as compared with baseline).11 Severe bronchial hyperresponsiveness was defined as a methacholine challenge dose of less than 1 μmol causing a 20% reduction in FEV1. A reduced t PTEF/t E was defined as a value at or below the median or at or below 0.20, and reduced respiratory-system compliance was defined as a value at or below the median.

Subjects

Among 802 children for whom lung-function measurements were performed shortly after birth, we included in the present study 616 children (77%) whose parents completed an extensive structured interview at the 10-year follow-up evaluation (mean age, 10.9±0.8 years). Sufficient information was available to classify 614 children as having a history of asthma and 606 as having current asthma. Baseline characteristics of the current study population as compared with the 3140 children who were enrolled in the cohort at birth but were not included in the present study did not differ significantly with respect to sex, birth weight, rates of parental asthma or rhinoconjunctivitis, and rate of maternal smoking during pregnancy; birth length was slightly longer (mean, 0.7±0.1 cm; P<0.001). The mean t PTEF/t E (in 614 children) and the respiratory-system compliance (expressed in milliliters per centimeter of water) are resistance (pressure [expressed in centimeters of water] divided by flow [expressed in milliliters per second]) (in 500 children) shortly after birth were not significantly different between the 614 children included in the follow-up and the 188 children in whom these measurements were performed but who did not participate in the 10-year follow-up (Table 1Table 1Baseline Characteristics of the Children at or Shortly after Birth.).

Measurements of Lung Function

Measurements of lung function were performed shortly after birth with the use of a face mask while the infants were awake and quietly breathing. Flow was measured with a pneumotachograph (8311 series, Hans Rudolph) (flow range, 0 to 10 liters per minute), and signal processing was performed with the use of the SensorMedics 2600 system.15 Volume was calculated by digital integration of the flow signal. Four representative tidal flow-volume loops were chosen for further analysis.15 The tidal flow-volume ratio t PTEF/t E was calculated by separate measurements of time to peak expiratory flow (t PTEF) and total expiratory time (t E) with the use of a computer.

Passive respiratory mechanics were measured with the single-breath technique9 by means of automatic airway occlusion at end inspiration. Occlusion was maintained until equilibration between alveolar and airway pressure (variation of less than ±0.125 cm H2O) had persisted for 100 msec. The expiratory flow-volume loop obtained on slide valve opening was registered and used for calculations of respiratory-system compliance and resistance.15,16 A mean of 4 (range, 2 to 14) passive occlusion curves were stored for analysis.

Statistical Analysis

Results are given as mean values with 95% confidence intervals (CIs), unless otherwise stated. Values for t PTEF/t E and respiratory-system compliance were dichotomized according to the median values. For t PTEF/t E, we also performed an analysis dichotomized according to a value of 0.20, which has previously been found among children with obstructive airway diseases after bronchial provocation or before bronchodilation17 and as a predictor for recurrent bronchial obstruction by 2 years of age.6

Means for various lung-function measures at birth were compared between children with current asthma or a history of asthma and those with no diagnosis of asthma, with the use of Student's t-test. Categorical values were compared between groups with the use of the chi-square test.

Logistic regression was used to estimate odds ratios and 95% CIs for current asthma and a history of asthma associated with these lung function measures, with adjustment for relevant covariates. However, the inclusion of birth weight and birth length did not significantly influence the estimates of a history of asthma and current asthma in the logistic-regression analyses and thus these were not retained in the multivariate analyses. A two-sided P value of less than 0.05 was considered to indicate statistical significance. Analyses were performed with SPSS software, version 11.0. Adjustment was not made for multiple comparisons.

Results

As previously reported among this cohort,11 the prevalence of a history of asthma was 20.2%, and the prevalence of current asthma was 11.1% at 10 years of age. As compared with children who did not have a history of asthma at follow-up, children with a history of asthma had significantly lower mean values for t PTEF/t E and respiratory-system compliance. Children with current asthma at the 10-year follow-up also had a significantly lower mean t PTEF/t E shortly after birth than did children without asthma, but their respiratory-system compliance was not significantly different (Table 2Table 2Lung Function at Birth According to the Presence or Absence of a History of Asthma during the First 10 Years of Life and the Presence of Asthma at 10 Years of Age.).

In analyses categorizing lung-function measures at birth, children whose values for t PTEF/t E were at or below the median were significantly more likely at 10 years of age to have a history of asthma and current asthma than were children with values above the median. Children with t PTEF/t E values at or below 0.20 were more likely to have a history of asthma but not to have current asthma, as compared with children with values above 0.20. Likewise, children with values for respiratory-system compliance that were at or below the median, as compared with children whose values were above the median, were significantly more likely to have a history of asthma and to have current asthma by 10 years of age (Table 3Table 3Outcomes at 10 Years of Age According to Lung Function Measured Shortly after Birth.). We found no significant associations between respiratory-system resistance shortly after birth and the subsequent development of asthma.

We performed a post hoc analysis in which we categorized children as being at high risk if the value for t PTEF/t E was 0.20 or lower and the value for respiratory-system compliance was at or below the median (33 children). As compared with the 467 remaining children, the high-risk group was significantly more likely to have a history of asthma (45.5% vs. 19.1%, P<0.001) and current asthma (28.1% vs. 10.0%, P=0.002).

Children with t PTEF/t E values at or below the median were also significantly more likely to have severe bronchial hyperresponsiveness at the 10-year follow-up and were more likely to use inhaled corticosteroids than were children with a t PTEF/t E above this cutoff value (Table 3). A t PTEF/t E at or below 0.20 was predictive of severe bronchial hyperresponsiveness at 10 years, but not of inhaled-corticosteroid use. A value for respiratory-system compliance that was at or below the median shortly after birth was not a significant predictor of either of these outcomes (Table 3).

We have previously reported that FEV1 (percent predicted) and forced expiratory flow at 50% of forced vital capacity (FVC) were significantly lower among children with a history of asthma and those with current asthma at 10 years than among children without asthma in this cohort.11 However, we found that values at or below the median for t PTEF/t E and respiratory-system compliance shortly after birth were not consistently related to forced flow-volume values (as percent predicted) at 10 years of age, and observed relationships were weak (Table 3). The t PTEF/t E shortly after birth correlated weakly with the midexpiratory flow rate at 10 years of age (r=0.10, P=0.01), but not with FEV1 or FVC. Lung-function measures shortly after birth were not significantly associated with positive results on exercise testing at 10 years (data not shown).

After adjustment for sex, parental rhinoconjunctivitis, parental asthma, and maternal smoking during pregnancy, a reduced tPTEF/tE (at or below the median, or at or below 0.20) and reduced respiratory-system compliance (at or below the median) remained significant risk factors for a history of asthma and current asthma at 10 years (Table 4Table 4Lung-Function Measurements Shortly after Birth as Predictors of Asthma at 10 Years of Age.); male sex was an independent risk factor for these outcomes (odds ratio, 1.61; 95% CI, 1.00 to 2.57; and odds ratio, 2.70; 95% CI, 1.41 to 5.18, respectively). Table 4 also shows the sensitivity, specificity, and positive and negative predictive values of reduced t PTEF/t E and respiratory-system compliance shortly after birth for asthma in later life. Reduced values for any of these measures had low positive predictive values (15% or less) for asthma at age 10.

Discussion

This study shows that reduced lung-function values within a few days after birth, as measured by tidal flow-volume loops and passive respiratory mechanics, are significant risk factors for asthma in the first 10 years of life. A reduced value for t PTEF/t E or respiratory-system compliance (i.e., at or below the median) shortly after birth was associated with current asthma at 10 years of age; a reduced value for t PTEF/t E (but not for respiratory-system compliance) was also a significant predictor of severe bronchial hyperresponsiveness and the use of inhaled corticosteroids at 10 years of age.

Our finding of significant associations between measures of reduced lung function shortly after birth and later asthma extends previous findings relating lung function in early life to the presence or absence of childhood respiratory illness. In previous studies, reduced t PTEF/t E was reported to precede wheeze-associated lower respiratory tract illness in early life.1,2,6,18 Martinez et al. found an increased rate of recurrent wheezing at 1 year of age2 and at 3 years of age18 among infants who had had reduced t PTEF/t E in the first 3 months of life. In the Perth cohort, infants with reduced t PTEF/t E at 1 month of age were at increased risk for a doctor's diagnosis of asthma at 2 years,7 and reduced respiratory-system compliance at 1 month of age was associated with persistent wheezing throughout the first 2 years of life.4 However, not all studies have shown associations between lung-function measures in early life and assessments in later childhood. Reduced V̇maxFRC in the first few months of life (an assessment that requires that an infant be sleeping or sedated) was not significantly associated with wheezing after 3 years in the Tucson study,19 whereas reduced V̇maxFRC at 1 month of life was associated with wheezing, but not asthma, at 6 and 11 years in the Perth study.8

We found that associations between reduced t PTEF/t E and respiratory-system compliance shortly after birth and asthma by 10 years of age remained significant after adjustment for exposure to intrauterine tobacco smoke, parental asthma or rhinoconjunctivitis, and sex. The odds ratios for asthma in association with reductions in these early-life lung-function measures are similar to those previously reported in association with a family history of asthma.20

Whereas V̇maxFRC, and to some extent tidal flow-volume measures, are thought to reflect airway caliber, t PTEF/t E seems to be a complex measure of lung function that includes airway size and mechanical properties of the lung and chest,21-24 as well as respiratory control.25 Direct comparisons between V̇maxFRC and tidal flow-volume measures or passive respiratory mechanics (respiratory-system compliance or resistance) are therefore not possible. Thus, although a small airway caliber shortly after birth may be a risk factor for obstructive airway disease in the first years of life,2 the present findings suggest that other airway (or lung) characteristics, including control of breathing shortly after birth, also identify children at increased risk for asthma in later life. The small but significant differences in lung function shortly after birth between children in whom asthma subsequently developed and those in whom it did not suggest that markers for increased risk are already detectable at birth.

It is important to note that the clinical implications of reduced lung function shortly after birth on an individual level are unclear. Variations of lung function between persons as well as within an individual person a few days after birth are well recognized,9 and our results indicate that these lung-function measures have low positive predictive value for later asthma. Thus, our data would not support the use of such measures as screening tests for the risk of subsequent asthma.

The present study included children who were representative of the native population of urban Oslo. The design was prospective, and parents or guardians, children, and those who evaluated the children at 10 years of age were unaware of the measurements of lung function shortly after birth. The 77% follow-up rate, as well as the similarity at baseline between children who were evaluated at 10 years of age and those who were not, makes it unlikely that selection bias substantially affected our results.

In the present study, a t PTEF/t E value below 0.20 shortly after birth — a cutoff point previously associated with an increased risk of recurrent bronchial obstruction — was not significantly associated with current asthma at 10 years of age, as opposed to a t PTEF/t E value at or below the median value shortly after birth. A possible explanation for this finding is the smaller number of infants who were categorized as having reduced lung function when the cutoff value of 0.20 was used. Since we performed many tests, it is possible that some significant results were due to chance. However, the consistency of the findings for various outcomes and lung-function measures supports the validity of relationships between measures of lung function in early life and subsequent asthma. The lack of similar methods for assessing lung function during the neonatal period and at 10 years of age makes it difficult to study the evolution of lung function over time and may explain why these lung-function measures at birth were poor predictors of forced flow volume measured at 10 years of age.

In summary, reduced lung function a few days after birth as determined by simple measures of tidal breathing and passive respiratory mechanics in awake, newborn infants seems to be a risk factor for asthma within the first 10 years of life. These results suggest that alterations of airway function associated with later asthma may be present and detectable a few days after birth.

Supported by grants to the Environment and Childhood Asthma study from the Norwegian Research Council, the University of Oslo, the Norwegian Foundation for Health and Rehabilitation, the Eastern Norway Regional Health Authority, the Norwegian Association of Asthma and Allergy, the Kloster Foundation, Voksentoppen BKL, AstraZeneca, Pharmacia Diagnostics, and the Hakon Group.

Dr. Håland reports having received lecture fees from GlaxoSmithKline and AstraZeneca. Dr. Lødrup Carlsen reports being a member of a Novartis advisory board and having received lecture fees from AstraZeneca, GlaxoSmithKline, the UCB Institute of Allergy, and Merck. Dr. Devulapalli reports having received an educational research grant from AstraZeneca. Dr. Pettersen reports having received lecture fees from AstraZeneca, GlaxoSmithKline, and Merck. Dr. Carlsen reports being a member of a GlaxoSmithKline advisory board and having received lecture fees from Merck, AstraZeneca, and Schering-Plough. No other potential conflict of interest relevant to this article was reported.

We are indebted to all the children and parents participating in the study, and to Solveig Knutsen, Trine Stensrud, Jorun Wikstrand, Ingebjørg Coward, and Anne Cathrine Mork Wik for skillfully conducting the 10-year follow-up study.

Source Information

From the Department of Pediatrics, Division of Woman and Child (G.H., K.C.L.C., C.S.D., M.C.M.-K.), and the Center for Clinical Research (L.S.), Ullevål University Hospital; Voksentoppen, Department of Pediatrics, Rikshospitalet–Radiumhospitalet Medical Center (G.H., C.S.D., M.P., K.-H.C.); and the Faculty of Medicine, University of Oslo (K.C.L.C., C.S.D., M.C.M.-K., K.-H.C.) — all in Oslo.

Address reprint requests to Dr. Håland at Voksentoppen, Department of Pediatrics, Rikshospitalet–Radiumhospitalet Medical Center, Ullveien 14, N-0491 Oslo, Norway, or at .

The study was performed by members of the ORAACLE (Oslo Research Group for Asthma and Allergy in Childhood, the Lung and Environment), which is part of the Global Allergy and Asthma European Network (GA2LEN).

References

References

  1. 1

    Yuksel B, Greenough A, Giffin F, Nicolaides KH. Tidal breathing parameters in the first week of life and subsequent cough and wheeze. Thorax 1996;51:815-818
    CrossRef | Web of Science | Medline

  2. 2

    Martinez FD, Morgan WJ, Wright AL, Holberg CJ, Taussig LM. Diminished lung function as a predisposing factor for wheezing respiratory illness in infants. N Engl J Med 1988;319:1112-1117
    Full Text | Web of Science | Medline

  3. 3

    Tager IB, Hanrahan JP, Tosteson TD, et al. Lung function, pre- and post-natal smoke exposure, and wheezing in the first year of life. Am Rev Respir Dis 1993;147:811-817
    Web of Science | Medline

  4. 4

    Young S, Arnott J, O'Keeffe PT, Le Souef PN, Landau LI. The association between early life lung function and wheezing during the first 2 yrs of life. Eur Respir J 2000;15:151-157
    CrossRef | Web of Science | Medline

  5. 5

    Murray CS, Pipis SD, McArdle EC, Lowe LA, Custovic A, Woodcock A. Lung function at one month of age as a risk factor for infant respiratory symptoms in a high risk population. Thorax 2002;57:388-392
    CrossRef | Web of Science | Medline

  6. 6

    Lodrup Carlsen KC, Carlsen KH, Nafstad P, Bakketeig L. Perinatal risk factors for recurrent wheeze in early life. Pediatr Allergy Immunol 1999;10:89-95
    CrossRef | Web of Science | Medline

  7. 7

    Young S, Arnott J, Le Souef PN, Landau LI. Flow limitation during tidal expiration in symptom-free infants and the subsequent development of asthma. J Pediatr 1994;124:681-688
    CrossRef | Web of Science | Medline

  8. 8

    Turner SW, Palmer LJ, Rye PJ, et al. The relationship between infant airway function, childhood airway responsiveness, and asthma. Am J Respir Crit Care Med 2004;169:921-927
    CrossRef | Web of Science | Medline

  9. 9

    Lodrup Carlsen KC, Magnus P, Carlsen KH. Lung function by tidal breathing in awake healthy newborn infants. Eur Respir J 1994;7:1660-1668
    CrossRef | Web of Science | Medline

  10. 10

    Lodrup Carlsen KC, Jaakkola JJ, Nafstad P, Carlsen KH. In utero exposure to cigarette smoking influences lung function at birth. Eur Respir J 1997;10:1774-1779
    CrossRef | Web of Science | Medline

  11. 11

    Lodrup Carlsen KC, Haland G, Devulapalli CS, et al. Asthma in every fifth child in Oslo, Norway: a 10-year follow up of a birth cohort study. Allergy 2006;61:454-460
    CrossRef | Web of Science | Medline

  12. 12

    Crapo RO, Casaburi R, Coates AL, et al. Guidelines for methacholine and exercise challenge testing -- 1999: this official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 2000;161:309-329
    Web of Science | Medline

  13. 13

    Carlsen KH, Engh G, Mork M. Exercise-induced bronchoconstriction depends on exercise load. Respir Med 2000;94:750-755
    CrossRef | Web of Science | Medline

  14. 14

    Nystad W, Nafstad P, Harris JR. Physical activity affects the prevalence of reported wheeze. Eur J Epidemiol 2001;17:209-212
    CrossRef | Web of Science | Medline

  15. 15

    Lodrup KC, Mowinckel P, Carlsen KH. Lung function measurements in awake compared to sleeping newborn infants. Pediatr Pulmonol 1992;12:99-104
    CrossRef | Web of Science | Medline

  16. 16

    LeSouef PN, England SJ, Bryan AC. Passive respiratory mechanics in newborns and children. Am Rev Respir Dis 1984;129:552-556
    Web of Science | Medline

  17. 17

    Lodrup Carlsen KC. Tidal breathing analysis in infants and preschool children: tidal flow-volume loops. Eur Respir Monogr 1997;5:27-57

  18. 18

    Martinez FD, Morgan WJ, Wright AL, Holberg C, Taussig LM. Initial airway function is a risk factor for recurrent wheezing respiratory illnesses during the first three years of life. Am Rev Respir Dis 1991;143:312-316
    Web of Science | Medline

  19. 19

    Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ. Asthma and wheezing in the first six years of life. N Engl J Med 1995;332:133-138
    Full Text | Web of Science | Medline

  20. 20

    Ronmark E, Jonsson E, Platts-Mills T, Lundback B. Incidence and remission of asthma in schoolchildren: report from the Obstructive Lung Disease in Northern Sweden studies. Pediatrics 2001;107:E37-E37
    CrossRef | Web of Science | Medline

  21. 21

    Banovcin P, Seidenberg J, Von der Hardt H. Assessment of tidal breathing patterns for monitoring of bronchial obstruction in infants. Pediatr Res 1995;38:218-220
    CrossRef | Web of Science | Medline

  22. 22

    Morris MJ, Lane DJ. Tidal expiratory flow patterns in airflow obstruction. Thorax 1981;36:135-142
    CrossRef | Web of Science | Medline

  23. 23

    Cutrera R, Filtchev SI, Merolla R, Willim G, Haluszka J, Ronchetti R. Analysis of expiratory pattern for monitoring bronchial obstruction in school-age children. Pediatr Pulmonol 1991;10:6-10
    CrossRef | Web of Science | Medline

  24. 24

    van der Ent CK, Brackel HJ, van der Laag J, Bogaard JM. Tidal breathing analysis as a measure of airway obstruction in children three years of age and older. Am J Respir Crit Care Med 1996;153:1253-1258
    Web of Science | Medline

  25. 25

    Seddon PC, Davis GM, Coates AL. Do tidal expiratory flow patterns reflect lung mechanics in infants? Am J Respir Crit Care Med 1996;153:1248-1252
    Web of Science | Medline

Citing Articles (48)

Citing Articles

  1. 1

    Magdy Zedan, Nehad Nasef, Mohamed El-Bayoumy, Mohamed El-Assmy, Gehan Attia, Mohamed Zedan, Angi AlWakeel, Shaimaa Kandil, Wafaa Laimon, Ashraf Fouda. (2012) Does Decline of Lung Function in Wheezy Infants Justify the Early Start of Controller Medications?. The Indian Journal of Pediatrics
    CrossRef

  2. 2

    A. John Henderson, John O. Warner. (2012) Fetal origins of asthma. Seminars in Fetal and Neonatal Medicine
    CrossRef

  3. 3

    Fernando D. Martinez. (2011) New insights into the natural history of asthma: Primary prevention on the horizon. Journal of Allergy and Clinical Immunology 128:5, 939-945
    CrossRef

  4. 4

    Tale M. Torjussen, Karin C. Lødrup Carlsen, Monica C. Munthe-Kaas, Petter Mowinckel, Kai-Håkon Carlsen, Peter J. Helms, Jorrit Gerritsen, Moira K. Whyte, Warren Lenney, Dag E. Undlien, Kevin V. Shianna, Guohua Zhu, Sreekumar G. Pillai. (2011) Alpha-nicotinic acetylcholine receptor and tobacco smoke exposure: Effects on bronchial hyperresponsiveness in children. Pediatric Allergy and Immunologyno-no
    CrossRef

  5. 5

    Theresa W. Guilbert, Anne Marie Singh, Zoran Danov, Michael D. Evans, Daniel J. Jackson, Ryan Burton, Kathy A. Roberg, Elizabeth L. Anderson, Tressa E. Pappas, Ronald Gangnon, James E. Gern, Robert F. Lemanske. (2011) Decreased lung function after preschool wheezing rhinovirus illnesses in children at risk to develop asthma. Journal of Allergy and Clinical Immunology 128:3, 532-538.e10
    CrossRef

  6. 6

    Jose A Castro-Rodriguez. (2011) The Asthma Predictive Index: early diagnosis of asthma. Current Opinion in Allergy and Clinical Immunology 11:3, 157-161
    CrossRef

  7. 7

    Anne Kørner Bueso, Sveinung Berntsen, Petter Mowinckel, Lene Frost Andersen, Karin C. Lødrup Carlsen, Kai-Håkon Carlsen. (2011) Dietary intake in adolescents with asthma - potential for improvement. Pediatric Allergy and Immunology 22:1-Part-I, 19-24
    CrossRef

  8. 8

    Erik Melén, Alvin T Kho, Sunita Sharma, Roger Gaedigk, J Steven Leeder, Thomas J Mariani, Vincent J Carey, Scott T Weiss, Kelan G Tantisira. (2011) Expression analysis of asthma candidate genes during human and murine lung development. Respiratory Research 12:1, 86
    CrossRef

  9. 9

    K.C. Pike, M.J. Rose-Zerilli, E. Caffrey Osvald, H.M. Inskip, K.M. Godfrey, S.R. Crozier, G. Roberts, J.B. Clough, J.W. Holloway, J.S. Lucas, . (2011) The relationship between infant lung function and the risk of wheeze in the preschool years. Pediatric Pulmonology 46:1, 75-82
    CrossRef

  10. 10

    K. C. Lødrup Carlsen, P. Mowinckel, B. Granum, K.-H. Carlsen. (2010) Can childhood asthma be predicted at birth?. Clinical & Experimental Allergy 40:12, 1767-1775
    CrossRef

  11. 11

    Daniel T Swarr, Hakon Hakonarson. (2010) Unraveling the complex genetic underpinnings of asthma and allergic disorders. Current Opinion in Allergy and Clinical Immunology 10:5, 434-442
    CrossRef

  12. 12

    Esteban Keklikian, Manuel Sanchez-Solis, Angel Jose Bonina, Alejandra Meneguzzi, Maria Dolores Pastor-Vivero, Pedro Mondejar-Lopez, Luis Garcia-Marcos. (2010) Do risk factors for persistent asthma modify lung function in infants and young children with recurrent wheeze?. Pediatric Pulmonology 45:9, 914-918
    CrossRef

  13. 13

    Karin C. Lødrup Carlsen, Chandra Sekhar Devulapalli, Petter Mowinckel, Geir Håland, Monica Cheng Munthe-Kaas, Kai-Håkon Carlsen. (2010) Lung function at 10 yrs is not improved by early corticosteroid treatment in asthmatic children. Pediatric Allergy and Immunology 21:5, 814-822
    CrossRef

  14. 14

    Hans Bisgaard, Klaus Bønnelykke. (2010) Long-term studies of the natural history of asthma in childhood. Journal of Allergy and Clinical Immunology 126:2, 187-197
    CrossRef

  15. 15

    Mark D. Miller, Melanie A. Marty. (2010) Impact of Environmental Chemicals on Lung Development. Environmental Health Perspectives 118:8, 1155-1164
    CrossRef

  16. 16

    J. M. Antó, J. Sunyer, X. Basagaña, R. Garcia-Esteban, I. Cerveri, R. De Marco, J. Heinrich, C. Janson, D. Jarvis, M. Kogevinas, N. Kuenzli, B. Leynaert, C. Svanes, M. Wjst, T. Gislason, P. Burney. (2010) Risk factors of new-onset asthma in adults: a population-based international cohort study. Allergy 65:8, 1021-1030
    CrossRef

  17. 17

    Cindy McEvoy, Diane Schilling, Dawn Peters, Carrie Tillotson, Patricia Spitale, Linda Wallen, Sally Segel, Susan Bowling, Michael Gravett, Manuel Durand. (2010) Respiratory compliance in preterm infants after a single rescue course of antenatal steroids: a randomized controlled trial. American Journal of Obstetrics and Gynecology 202:6, 544.e1-544.e9
    CrossRef

  18. 18

    R. J. Bertelsen, K. C. L. Carlsen, B. Granum, K.-H. Carlsen, G. Håland, C. S. Devulapalli, M. C. Munthe-Kaas, P. Mowinckel, M. Løvik. (2010) Do allergic families avoid keeping furry pets?. Indoor Air 20:3, 187-195
    CrossRef

  19. 19

    Monica Cheng Munthe-Kaas, Tale Mæhre Torjussen, Kristina Gervin, Karin C. Lødrup Carlsen, Kai Håkon Carlsen, Berit Granum, Hanne Sagsveen Hjorthaug, Dag Undlien, Robert Lyle. (2010) CD14 polymorphisms and serum CD14 levels through childhood: A role for gene methylation?. Journal of Allergy and Clinical Immunology 125:6, 1361-1368
    CrossRef

  20. 20

    Randi J. Bertelsen, Karin C. Lødrup Carlsen, Kai-Håkon Carlsen. (2010) Rhinitis in children: Co-morbidities and phenotypes. Pediatric Allergy and Immunology 21:4p1, 612-622
    CrossRef

  21. 21

    Anne M. Fitzpatrick, William Gerald Teague. (2010) Severe Asthma in Children: Insights from the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. Pediatric Allergy, Immunology, and Pulmonology 23:2, 131-138
    CrossRef

  22. 22

    Graham Devereux. (2010) Session 1: Allergic disease Nutrition as a potential determinant of asthma. Proceedings of the Nutrition Society 69:01, 1
    CrossRef

  23. 23

    C. Sachs-Olsen, K. C. Lødrup Carlsen, P. Mowinckel, G. Håland, C. S. Devulapalli, M. C. Munthe-Kaas, K.-H. Carlsen. (2010) Diagnostic value of exhaled nitric oxide in childhood asthma and allergy. Pediatric Allergy and Immunology 21:1-Part-II, e213-e221
    CrossRef

  24. 24

    Stephen T Holgate. (2010) Has the time come to rethink the pathogenesis of asthma?. Current Opinion in Allergy and Clinical Immunology 10:1, 48-53
    CrossRef

  25. 25

    Stephen T. Holgate, Hasan S. Arshad, Graham C. Roberts, Peter H. Howarth, Philipp Thurner, Donna E. Davies. (2009) A new look at the pathogenesis of asthma. Clinical Science 118:7, 439-450
    CrossRef

  26. 26

    N. E. Reijmerink, M. Kerkhof, G. H. Koppelman, J. Gerritsen, J. C. de Jongste, H. A. Smit, B. Brunekreef, D. S. Postma. (2009) Smoke exposure interacts with ADAM33 polymorphisms in the development of lung function and hyperresponsiveness. Allergy 64:6, 898-904
    CrossRef

  27. 27

    Geir Håland, Karin Cecilie Lødrup Carlsen, Petter Mowinckel, Monica Cheng Munthe-Kaas, Chandra Sekhar Devulapalli, Sveinung Berntsen, Kai-Håkon Carlsen. (2009) Lung function at 10 yr is not impaired by early childhood lower respiratory tract infections. Pediatric Allergy and Immunology 20:3, 254-260
    CrossRef

  28. 28

    Karin C Lødrup Carlsen, Geir Håland, Kai-Håkon Carlsen. (2009) Natural history of lung function in health and diseases. Current Opinion in Allergy and Clinical Immunology 9:2, 146-150
    CrossRef

  29. 29

    Padmaja Subbarao, Allan Becker, Jeffrey R Brook, Denise Daley, Piush J Mandhane, Gregory E Miller, Stuart E Turvey, Malcolm R Sears. (2009) Epidemiology of asthma: risk factors for development. Expert Review of Clinical Immunology 5:1, 77-95
    CrossRef

  30. 30

    Dawn L. DeMeo, Scott T. Weiss. 2009. Epidemiology. , 9-21.
    CrossRef

  31. 31

    Andrew Bush. 2009. Pediatric AsthmaHow Early Life Events Cause Lifelong Respiratory Disease. , 791-821.
    CrossRef

  32. 32

    Stefano Guerra, Fernando D. Martinez. 2009. Natural History. , 23-35.
    CrossRef

  33. 33

    Peter D Sly, Attilio L Boner, Bengt Björksten, Andy Bush, Adnan Custovic, Philippe A Eigenmann, James E Gern, Jorrit Gerritsen, Eckard Hamelmann, Peter J Helms, Robert F Lemanske, Fernando Martinez, Soren Pedersen, Harald Renz, Hugh Sampson, Erika von Mutius, Ulrich Wahn, Patrick G Holt. (2008) Early identification of atopy in the prediction of persistent asthma in children. The Lancet 372:9643, 1100-1106
    CrossRef

  34. 34

    Susanne Lau. (2008) Transition from childhood to adult asthma. The Lancet 372:9643, 1014-1015
    CrossRef

  35. 35

    Nikolaos G. Papadopoulos, Magnus Borres, James Gern, Antonio Nieto. (2008) New visions in respiratory allergy (asthma and allergic rhinitis): An iPAC summary and future trends. Pediatric Allergy and Immunology 19, 51-59
    CrossRef

  36. 36

    A. Lang, K. H. Carlsen, G. Haaland, C. S. Devulapalli, M. Munthe-Kaas, P. Mowinckel, K. Carlsen. (2008) Severe asthma in childhood: assessed in 10year olds in a birth cohort study. Allergy 63:8, 1054-1060
    CrossRef

  37. 37

    Jonathan Grigg. (2008) Asthma year in review 2006–7. Paediatric Respiratory Reviews 9:2, 134-138
    CrossRef

  38. 38

    John W. Holloway, Ian A. Yang, Stephen T. Holgate. (2008) Interpatient variability in rates of asthma progression: Can genetics provide an answer?. Journal of Allergy and Clinical Immunology 121:3, 573-579
    CrossRef

  39. 39

    J.A. Stockman. (2008) Reduced Lung Function at Birth and the Risk of Asthma at 10 Years of Age. Yearbook of Pediatrics 2008, 490-491
    CrossRef

  40. 40

    Monica Cheng Munthe-Kaas, Kai Håkon Carlsen, Geir Håland, Chandra Sekhar Devulapalli, Kristina Gervin, Thore Egeland, Karin Lødrup Carlsen, Dag Undlien. (2008) T cell–specific T-box transcription factor haplotype is associated with allergic asthma in children. Journal of Allergy and Clinical Immunology 121:1, 51-56
    CrossRef

  41. 41

    Paul V. Williams. (2007) Pediatric Asthma: A Year in Review. Pediatric Asthma, Allergy & Immunology 20:3, 138-145
    CrossRef

  42. 42

    Ursula Kiechl-Kohlendorfer, Elisabeth Horak, Wilfried Mueller, Robert Strobl, Claudia Haberland, Franz-Martin Fink, Michaela Schwaiger, Karl-Heinz Gutenberger, Hannes Reich, Dagmar Meraner, Stefan Kiechl. (2007) Neonatal characteristics and risk of atopic asthma in schoolchildren: results from a large prospective birth-cohort study. Acta Paediatrica 96:11, 1606-1610
    CrossRef

  43. 43

    M. C. Munthe-Kaas, K. L. Carlsen, K. H. Carlsen, T. Egeland, G. Håland, C. S. Devulapalli, H. Akselsen, D. Undlien. (2007) HLA Dr-Dq haplotypes and the TNFA-308 polymorphism: associations with asthma and allergy. Allergy 62:9, 991-998
    CrossRef

  44. 44

    Geir Håland, Kai-Håkon Carlsen, Chandra Sekhar Devulapalli, Morten Pettersen, Petter Mowinckel, Karin C. Lødrup Carlsen. (2007) Lung function development in the first 2yr of life is independent of allergic diseases by 2yr. Pediatric Allergy and Immunology 18:6, 528-534
    CrossRef

  45. 45

    Chandra Sekhar Devulapalli, Karin C. Lødrup Carlsen, Geir Håland, Monica C. Munthe-Kaas, Morten Pettersen, Petter Mowinckel, Kai-Håkon Carlsen. (2007) No evidence that early use of inhaled corticosteroids reduces current asthma at 10 years of age. Respiratory Medicine 101:8, 1625-1632
    CrossRef

  46. 46

    P. Latzin, G. Hafen. (2007) Lungenfunktion im Säuglings- und Kleinkindalter. Der Pneumologe 4:4, 233-240
    CrossRef

  47. 47

    Stanley J. Szefler. (2007) Advances in pediatric asthma 2006. Journal of Allergy and Clinical Immunology 119:3, 558-562
    CrossRef

  48. 48

    Wan C Tan. (2007) Insights into Early Treatment of Mild Asthma. Pediatric Drugs 9:4, 219-226
    CrossRef